Status:
COMPLETED
Ovarian Stimulation Using Recombinant Follicle-stimulating Hormone (FSH) and Gonadotrophin Releasing Hormone (GnRH) Agonist in Alternate Days
Lead Sponsor:
Fertility - Assisted Fertilization Center
Conditions:
Infertility
Eligibility:
FEMALE
Up to 35 years
Phase:
NA
Brief Summary
The present prospective study was designed to compare the effects of administering a daily dose of gonadotrophin releasing hormone (GnRH) antagonist vs. an alternate-day dosage of GnRH agonist on ovar...
Detailed Description
Inclusion criteria were as follows: women of good physical and mental health, under 37 years old, with regular menstrual cycles of 25-35 days, normal basal FSH and luteinizing hormone (LH) levels, bod...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- women of good physical and mental health
- under 37 years old, with regular menstrual cycles of 25-35 days
- normal basal FSH and LH levels
- BMI less than 30 kg/m2
- presence of both ovaries and intact uterus
- absence of polycystic ovaries
- endometriosis, or gynaecological / medical disorders and a negative result in a screening for sexually transmitted diseases
- all patients signed a written informed consent form
- no patient had received any hormone therapy for at least 60 days preceding the study.
Exclusion
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT01468441
Start Date
September 1 2011
End Date
March 1 2012
Last Update
July 13 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fertility - Assisted Fertilization Center
São Paulo, São Paulo, Brazil, 01401-002